Alaunos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MSD Partners, L.P.(6.3%),MSD Credit Opportunity Master Fund, L.P.(6.3%), etc.

SEC · Nov 15, 2024 06:05

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Alaunos Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MSD Partners, L.P.(6.3%),MSD Credit Opportunity Master Fund, L.P.(6.3%), etc.

Risk Disclaimer